Ruxolitinib
SELINEXOR AND RUXOLITINIB’S PHASE III TRIAL IN JAKI-NAIVE MYELOFIBROSIS BEGINS
SG Tylor
Source – Karyopharm Therapeutics Karyopharm Therapeutics has initiated a Phase III clinical trial (NCT04562389) to evaluate the effectiveness and safety ...
Evolution of Myelofibrosis Treatment Paradigm: Unleashing the Potential of Combination Therapies
SG Tylor
Introduction In the rapidly advancing field of myelofibrosis treatment, significant strides have been made in recent years, ushering in a ...
